Skip to main content

Jessica Hagen

By Jessica Hagen | 01:37 pm | September 22, 2023
Jennifer Mathieu, senior vice president of professional and government affairs at AMCP, provides an update on the Access to Prescription Digital Therapeutics Act 2023 moving through Congress.
By Jessica Hagen | 02:00 pm | September 21, 2023
The company will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets.
By Jessica Hagen | 12:34 pm | September 21, 2023
Postmenopausal patients can get a prescription for ASCEND Therapeutics' EstroGel by scheduling an appointment with a LifeMD provider through the pharma brand's website.
By Jessica Hagen | 02:03 pm | September 20, 2023
The company offers personalized care plans and connects patients with a coordinated care team, including dietitians, internists and gastroenterologists.
By Jessica Hagen | 10:33 am | September 20, 2023
Data exchange platform Briya and clinical trial-participant management platform Mural Health also secured investments.
By Jessica Hagen | 10:07 am | September 19, 2023
Kimmel Comprehensive Cancer Care Center will be added to AccessHope's National Cancer Institute-Designated Comprehensive Cancer Center partner network.
By Jessica Hagen | 10:04 am | September 19, 2023
The funds will be used to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
By Jessica Hagen | 03:01 pm | September 18, 2023
The care delivery enablement platform scored $8 million and now has a foothold in New Jersey, Pennsylvania, Texas, Florida and Maryland.
By Jessica Hagen | 12:39 pm | September 18, 2023
Medicare-focused virtual exercise platform Bold secured $17 million.
By Jessica Hagen | 02:08 pm | September 15, 2023
The pair will work to further the practice of radiology and patient care using innovation, such as theranostics, AI and digital health platforms.